Guardian Pharmacy Services GRDN Payments to Noncontrolling Interests

Payments to Noncontrolling Interests at other companies

Cardinal HealthCAH

$4M+33.3%

PACS GroupPACS

——

Other financials

Income statement

See full

Revenue$336.6M+2.2%

Gross profit$76.3M+18.6%

Operating income$17.7M+35.9%

Net income$13.3M+40.7%

EPS (diluted)$0.21+40.0%

Balance sheet

See full

Cash & equivalents$64.9M+364%

Total debt$36.9M+29.6%

Total equity$232.4M+42.4%

Total assets$426.9M+27.8%

Cash flow

See full

Operating cash flow$6.1M-65.5%

CapEx$495.0K-78.0%

Free cash flow$34.1M+69.8%

Valuation

See full

Market cap$2.48B+80.1%

Enterprise value$2.45B+76.1%

P/E46.8×—

P/S1.7×+0.6×

Profitability

See full

Gross margin20.9%+1.1pp

Operating margin5.3%—

Net margin3.6%+2.1pp

Returns & leverage

See full

Return on equity26.8%—

Debt / equity0.2×0.0×

Current ratio1.5×+0.3×

Where this comes from

Reported directly by Guardian Pharmacy Services in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToMinorityShareholders.

The official record: Guardian Pharmacy Services’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardian Pharmacy Services's payments to noncontrolling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Guardian Pharmacy Services's payments to noncontrolling interests?: Guardian Pharmacy Services (GRDN) reported payments to noncontrolling interests of $960K in Q1 2026.
How has Guardian Pharmacy Services's payments to noncontrolling interests changed year-over-year?: Guardian Pharmacy Services's payments to noncontrolling interests increased by 611.1% year-over-year, from $135K to $960K.